WORK Medical Technology Group Ltd. (WOK)
Automate Your Wheel Strategy on WOK
With Tiblio's Option Bot, you can configure your own wheel strategy including WOK - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol WOK
- Rev/Share 73.4784
- Book/Share 107.5194
- PB 0.0246
- Debt/Equity 1.0075
- CurrentRatio 1.137
- ROIC -0.1757
- MktCap 12426.0
- FreeCF/Share -90.2696
- PFCF -0.0009
- PE -0.086
- Debt/Assets 0.3758
- DivYield 0
- ROE -0.2836
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026
Published: December 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., Ltd. (“Hunan Saitumofei”) has entered into a one-year exclusive distribution agreement (the “Agreement”) with Shanghai Benke Medical Technology Co., Ltd. (“Shanghai Benke”) to promote and distribute its newly launched AI-Automated Blood Cell Morphology Analyzer (CM-B600) (the “Analyzer”) in East China throughout 2026. The collaboration is expected …
Read More
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
Published: December 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that its subsidiary, Hunan Saitumofei Co., Ltd., has received manufacturing approval from the Hunan Provincial Medical Products Administration for its Class II medical device, the Artificial Intelligence (“AI”)-Automated Human Blood Cell Morphology Analyzer. This regulatory approval represents a milestone in WORK Medical's research and development strategy and is expected to position the Company's new AI-driven device …
Read More
WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience
Published: October 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
Hangzhou, China, Oct. 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an investment agreement (the “Investment Agreement”) with Neologics Bioscience Inc. (“Neologics”), a Delaware-based medical technology company specializing in research and development of medical technologies, with a focus on the integration of artificial intelligence and medicine (the “R&D”), to invest US$1 million in cash to acquire a 10% equity interest in Neologics.
Read More
WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance
Published: October 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
Hangzhou, China, Oct. 10, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) granting the Company an additional 180-calendar-day period to regain compliance with the minimum bid price requirement pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Rule”).
Read More
WORK Medical Technology Group LTD Announces Pricing of $2.9 Million Registered Direct Offering
Published: September 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
Hangzhou, China, Sept. 25, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that it has entered into an agreement with several investors for the purchase and sale of 38,999,334 of the Company's Class A ordinary share, par value $0.0005 per share (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.075 per share in a registered direct offering (the “Offering”). The purchase price for …
Read More
Univest Securities, LLC Announces Closing of $5 Million Registered Offering for its Client WORK Medical Technology Group LTD (NASDAQ: WOK)
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
New York, New York, May 22, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered offering (the “Offering”) for its client WORK Medical Technology Group LTD (Nasdaq: WOK) (the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China.
Read More
WORK Medical Technology Group LTD Announces Pricing of Registered Offering
Published: May 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
Hangzhou, China, May 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced the pricing of a registered offering (the “Offering”) of 10,000,000 ordinary units (the “Ordinary Units”) or pre-funded units (the “Pre-funded Units”) in lieu thereof at an offering price of $0.50 per Ordinary Unit and $0.4995 per Pre-funded Unit.
Read More
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
Published: February 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
Hangzhou, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced a strategic partnership with Shanghai Chartwell Medical Device Co., Ltd.
Read More
WORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024
Published: February 14, 2025 by: PRNewsWire
Sentiment: Neutral
HANGZHOU, China , Feb. 14, 2025 /PRNewswire/ -- WORK Medical Technology Group LTD ("WORK Medical" or the "Company") (Nasdaq: WOK), a supplier of medical devices in China, today reported its financial results for the fiscal year ended September 30, 2024. Mr. Shuang Wu, Chairman and Chief Executive Officer of WORK Medical, remarked, "We are pleased to report our Company's performance for the fiscal year ended September 30, 2024.
Read More
About WORK Medical Technology Group Ltd. (WOK)
- IPO Date 2024-08-23
- Website https://www.hzsy120.com
- Industry Medical - Instruments & Supplies
- CEO Shuang Wu
- Employees 216